HSV-1 Antiviral Shortage Update: What Patients Need to Know in 2026

If you take acyclovir or valacyclovir to manage herpes simplex virus type 1 (HSV-1), you may have noticed that these medications aren't always easy to find. This article provides an up-to-date overview of HSV-1 antiviral availability in 2026, explains what's behind supply disruptions, and gives you clear steps to take if you're affected.

What Is the Current Status of HSV-1 Antiviral Supply in 2026?

The situation varies by formulation:

• Oral acyclovir (tablets, capsules, suspension): Generally available at most pharmacies in 2026. However, individual pharmacies may temporarily run out due to uneven distribution and high prescription volume. Spot shortages resolve within days to weeks.
• IV acyclovir: Continues to experience intermittent shortages in 2026. The injectable form has been on the shortage list since 2020. The situation is improving as manufacturers have increased production, but supply remains tight in some regions.
• Valacyclovir (Valtrex generic): Widely available. This is the most commonly prescribed HSV-1 antiviral in the U.S. and is generally well-stocked at major pharmacies.
• Famciclovir: Available. Generic famciclovir is a reliable alternative if acyclovir is temporarily out of stock at your pharmacy.

A Timeline of the HSV-1 Antiviral Shortage

Understanding the history helps explain where things stand today:

• 2020–2021: IV acyclovir shortages emerge, driven by COVID-19 pandemic manufacturing disruptions and increased hospitalizations requiring antiviral therapy
• 2022–2023: IV shortages persist; oral forms remain largely available nationally but spot shortages at individual pharmacies increase as HSV prescription volume climbs
• 2024–2025: Manufacturers begin increasing IV acyclovir production; oral antiviral supply continues to improve overall, though uneven distribution remains a challenge
• 2026: Oral HSV antivirals are generally available. IV acyclovir remains on the shortage watch list, improving but not fully resolved. Individual pharmacy availability varies.

Root Causes of the HSV-1 Antiviral Shortage

Several interconnected factors drive HSV-1 antiviral shortages:

• Thin profit margins on generics: Acyclovir went off-patent decades ago. With little financial incentive, few manufacturers produce it — especially the complex IV formulation. When one facility has problems, supply chains feel it immediately.
• Surging prescription volume: Growing public awareness of HSV, expanded suppressive therapy use, and telehealth making prescriptions easier to obtain have all driven prescription numbers higher — straining supply.
• Uneven distribution: Even when national supply is adequate, medications don't always reach every pharmacy equally. Smaller pharmacies and rural areas are disproportionately affected.
• Supply chain fragility: COVID-19 exposed vulnerabilities in global pharmaceutical supply chains — including raw material sourcing from overseas — that have not been fully resolved.

Who Is Most at Risk During an HSV-1 Antiviral Shortage?

Not all patients face equal risk from supply disruptions. The most vulnerable groups include:

• Patients on daily suppressive therapy who cannot interrupt treatment without risking viral reactivation
• Immunocompromised patients (HIV, transplant, chemotherapy) who depend on IV acyclovir for severe HSV-1 infections
• Patients with HSV keratitis (eye infections) who need consistent antiviral therapy to prevent vision-threatening flare-ups
• Patients in rural or underserved areas where pharmacy selection is limited

What Patients Should Do Right Now

Take these practical steps to protect your access to HSV-1 antiviral medication:

1. Refill early: Request refills 7–10 days before your last dose, not when you run out
2. Ask for a 90-day supply: Reduces trips to the pharmacy and minimizes risk of running out during spot shortages
3. Know your alternatives: Talk to your doctor about which alternative antiviral you could switch to if needed — famciclovir or valacyclovir if you're on acyclovir, and vice versa
4. Consider mail-order: Mail-order pharmacies often maintain better stock of generic medications and can ship a 90-day supply to your home
5. Use medfinder: If your pharmacy is out of stock, medfinder can quickly identify nearby pharmacies that have your medication available

The Outlook for HSV-1 Antiviral Supply

The long-term outlook is cautiously optimistic. Oral HSV antivirals are generally available and manufacturers are expanding capacity. However, the structural vulnerabilities — low margins, concentrated manufacturing, and rising demand — mean that spot shortages will continue to occur. Staying proactive is your best defense. If you're currently struggling to find your HSV-1 antiviral, use medfinder to locate a stocked pharmacy near you, and see our article on alternatives to HSV-1 antivirals if you need to switch medications.